Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Study Title
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
Teva Identifier
LBR-101-022
ClinicalTrials.gov Identifier
NCT02025556
Study Status
Completed
Trial Condition(s)
Episodic Migraine Headache
Interventions
Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 65 Years
Trial Duration
01/01/2014 - 03/01/2015
Phase
Phase 2

Study Type

Interventional